Mecasermin (Chiron/SkyePharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMecasermin (Chiron/SkyePharma)
Drug Alias NameInsulin-like growth factor-1Somatomedin-1 (Chiron/SkyePharma)Insulin-like growth factor-1(Chiron/SkyePharma)DepoIGF-1
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiron
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChironSkyepharma Ag
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A